Naming conventions for chemical classes follow a systematic approach that reflects these attributes. When a new class of compounds is identified, it undergoes a stringent process of validation and characterization. This process includes the elucidation of the molecular structure, understanding the mechanism by which these molecules exert their action, and defining the specificity with which they interact with their intended targets. This detailed research is necessary to establish a new class of compounds, and it is usually accompanied by peer-reviewed publications that introduce and substantiate the classification to the broader scientific community.
For a compound to be classified as an activator, it must be shown to increase the activity of its target, often through direct interaction that results in a change in the target's behavior or function. The development and recognition of a new class of activators such as EG666747 Activators would require comprehensive research, including the study of the compound's bioactivity, structure-activity relationships, and the biological pathways affected. Such rigorous scientific study is essential to confirm the relevance and legitimacy of a new chemical class before it gains acceptance and is documented in scientific nomenclature.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(+)-cis,trans-Abscisic acid | 21293-29-8 | sc-202103 sc-202103A | 500 µg 1 mg | $105.00 $188.00 | ||
Can activate NF-κB signaling, potentially leading to the induction of TRIM gene expression as part of an inflammatory response. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Affects gene expression and cell differentiation, which could potentially influence TRIM protein expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
A polyphenol that can modulate several signaling pathways and might affect the expression of TRIM proteins. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Alters the degradation of transcription factors and may influence TRIM protein expression as part of its anti-inflammatory and immunomodulatory effects. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Modulates various signaling pathways and could potentially influence the expression of TRIM proteins. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
An HDAC inhibitor that can alter chromatin structure and potentially affect the expression of TRIM genes by modulating gene accessibility. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Affects sirtuin and AMPK signaling, potentially influencing TRIM protein expression associated with metabolism and stress response. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt/β-catenin signaling, which could have downstream effects on TRIM protein expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Can lead to the accumulation of regulatory proteins and potentially affect the expression of TRIM proteins. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methylation inhibitor that could lead to the reactivation of silenced genes, potentially affecting TRIM protein expression. | ||||||